Cytokinetics Inc (CYTK)
66.35
-1.20
(-1.78%)
USD |
NASDAQ |
Apr 22, 16:00
66.27
-0.08
(-0.12%)
After-Hours: 20:00
Cytokinetics Cash and Short Term Investments (Quarterly): 614.82M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 614.82M |
| September 30, 2023 | 539.24M |
| June 30, 2023 | 565.72M |
| March 31, 2023 | 663.96M |
| December 31, 2022 | 782.58M |
| September 30, 2022 | 867.66M |
| June 30, 2022 | 586.03M |
| March 31, 2022 | 608.97M |
| December 31, 2021 | 471.64M |
| September 30, 2021 | 477.64M |
| June 30, 2021 | 350.30M |
| March 31, 2021 | 425.58M |
| December 31, 2020 | 464.06M |
| September 30, 2020 | 410.26M |
| June 30, 2020 | 213.06M |
| March 31, 2020 | 220.71M |
| December 31, 2019 | 225.11M |
| September 30, 2019 | 166.04M |
| June 30, 2019 | 172.87M |
| March 31, 2019 | 176.62M |
| December 31, 2018 | 198.73M |
| September 30, 2018 | 210.31M |
| June 30, 2018 | 231.94M |
| March 31, 2018 | 251.45M |
| December 31, 2017 | 268.89M |
| Date | Value |
|---|---|
| September 30, 2017 | 307.57M |
| June 30, 2017 | 312.05M |
| March 31, 2017 | 206.56M |
| December 31, 2016 | 156.25M |
| September 30, 2016 | 78.61M |
| June 30, 2016 | 90.34M |
| March 31, 2016 | 103.42M |
| December 31, 2015 | 111.44M |
| September 30, 2015 | 97.98M |
| June 30, 2015 | 105.18M |
| March 31, 2015 | 107.87M |
| December 31, 2014 | 83.23M |
| September 30, 2014 | 78.50M |
| June 30, 2014 | 77.75M |
| March 31, 2014 | 82.35M |
| December 31, 2013 | 77.73M |
| September 30, 2013 | 81.64M |
| June 30, 2013 | 75.65M |
| March 31, 2013 | 61.60M |
| December 31, 2012 | 74.00M |
| September 30, 2012 | 75.61M |
| June 30, 2012 | 90.48M |
| March 31, 2012 | 43.08M |
| December 31, 2011 | 49.02M |
| September 30, 2011 | 57.58M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
166.04M
Minimum
Sep 2019
867.66M
Maximum
Sep 2022
464.54M
Average
471.64M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 10.94B |
| Johnson & Johnson | 22.93B |
| Eli Lilly and Co | 2.928B |
| Viking Therapeutics Inc | 362.08M |
| Madrigal Pharmaceuticals Inc | 634.13M |